Abbott pays $385 million to settle Justice Department claims
The payment resolves 2022 infant formula recall lawsuits without admitting liability and concludes a closed criminal investigation. Regulatory tests showed negative results for pathogens.
See the latest news and media coverage for Abbott. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare products and technologies company
abbott.comLast updated
In short: Abbott received key device approvals for heart and diabetes care and settled long-running infant formula litigation for $670 million.
The payment resolves 2022 infant formula recall lawsuits without admitting liability and concludes a closed criminal investigation. Regulatory tests showed negative results for pathogens.
The sensor-enabled device delivers precision and flexible treatment options for patients seeking minimally invasive solutions for atrial fibrillation.
The TactiFlex Duo combines pulsed field and radiofrequency ablation. Trial data show 92.6% patients remained arrhythmia-free at follow-up, with a 98.3% safety profile and no major adverse events.
Designed to seal the heart's left atrial appendage, the device reduces stroke risk without long-term blood thinners, backed by high closure rates from the VERITAS clinical trial.
Abbott Laboratories (ABT) snapped six consecutive sessions of losses as the stock gained 1.21% to close at $103.18 on Monday.
Abbott Laboratories has agreed to pay more than $384 million to settle allegations related to contaminated infant formula, the U.S. Justice Department said on Monday.
By Connor Hart Abbott Laboratories said it received FDA approval for its TactiFlex Duo Ablation...
The IRS urged the U.S. Tax Court to validate regulations that the agency said required Abbott Laboratories to pay taxes on an $8 billion gain...
Track Abbott and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Abbott and other trending companies.